Results of the Medical Research Council (MRC) Myeloma IX study: Effects of zoledronic acid (ZOL) on overall survival (OS) in patients with multiple myeloma (MM)

✍ Scribed by G.J. Morgan*; F.E. Davies; W.M. Gregory; S.E. Bell; A.J. Szubert; N. Navarro Coy; A.J. Ashcroft; M.T. Drayson; R.G. Owen; G.H. Jackson; J.A. Child

• Book ID: 116323968
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 72 KB
• Volume: 48
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2010.10.043